Sensitive Affinity-Based Biosensor Using the Autocatalytic Activation of Trypsinogen Mutant by Trypsin with Low
Seonhwa Park1, Hyoeun Lee1, Haesik Yang1
1Department of Chemistry and Chemistry Institute for Functional Materials, Pusan National University, Busan 46241, Korea.
ACS Applied Bio Materials
|August 16, 2022
Summary
This study introduces a novel biosensor using a trypsinogen mutant for prostate-specific antigen (PSA) detection. The autocatalytic reaction significantly amplifies the signal, achieving a low detection limit for PSA.
Area of Science:
- Biochemistry
- Biosensor Technology
- Analytical Chemistry
Background:
- Protease-based autocatalytic reactions offer high signal amplification for biosensors.
- Limited availability of fast autocatalytic protease reactions and proenzyme self-activation hinder their application.
- Prostate-specific antigen (PSA) is a key biomarker for prostate cancer detection.
Purpose of the Study:
- To develop a highly sensitive biosensor for PSA detection using a self-propagating autocatalytic protease reaction.
- To overcome limitations of proenzyme self-activation and enhance signal amplification.
- To achieve a low detection limit for PSA using a novel autocatalytic approach.
Main Methods:
- A sandwich-type immunosensor was designed utilizing a trypsinogen mutant and trypsin as a catalytic label.
- Autocatalytic activation of the trypsinogen mutant by trypsin generated a cascade amplification.
- Electrochemical detection of liberated 4-aminophenol (AP) via redox cycling at a modified ITO electrode.
Main Results:
- The novel biosensor achieved a low detection limit of approximately 7 pg/mL for PSA.
- The autocatalytic activation strategy significantly reduced background noise and enhanced signal amplification.
- Compared to using trypsin alone (∼100 pg/mL), the autocatalytic method showed a substantial improvement in sensitivity.
Conclusions:
- Autocatalytic activation of proenzymes is a powerful strategy for signal amplification in biosensors.
- The developed biosensor demonstrates high sensitivity and low detection limits for PSA.
- This approach holds promise for sensitive and reliable biomarker detection in clinical diagnostics.


